Rollins, Inc.

NYSE:ROL

Personal Products & Services

Consumer Cyclical
$37.70 -0.53%

-$0.24 today

Market cap
$18.02B
Beta
0.73
P/E (TTM)
40.8
EPS (TTM)
$1.10
Dividend yield
1.59%
52W Low $44.43High $66.14

Volume 4.00M

Average 3.74M

ROL Other Investing Activities

Investing cash flows not reported separately.

Rollins, Inc.NYSE: ROL

Other Investing Activities · Q3 FY2026 · quarter ended Sep 2026

Other investing activities declines year over year

Q3 FY2026 other investing activities of $2.36M fell 32.6% year over year, behind the -29.0% change in trailing-twelve-month other investing activities. Sequentially, it rose 52.1% from the prior quarter. Over 3 fiscal years it compounded at -11.4% a year.

Context

  • Other investing activities amounted to 0.3% of revenue in FY2025, up 0.2 pp from a year earlier.
  • Other investing activities increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -32.6% toward the trailing-twelve-month pace of -29.0%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
$2.36M+52.1% QoQ
Last fiscal yearDec 2025
$10.91M+130.0% YoY
LTMSep 2026
$8.03M-29.0% YoY
Other Investing Activities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-32.6%——
1 year+130.0%——
3-year CAGR-11.4%——
5-year CAGR——
10-year CAGR——

Other Investing Activities history

USD · from the cash flow

Latest · FY2025
10.91M USD
Year-over-year change
+130.0%
4-year CAGR
-38.1%

Other Investing Activities vs competitors

How ROL compares with its peers on the latest reported figures

  • ROL's LTM Sep 2026 other investing activities of $8.03M is the 3rd largest of the 5 companies compared; the peer median is $433.5K.
  • Its year-over-year change of -29.0% is the 3rd highest of 5, against a peer median of +1.4%.
  • Other investing activities amounts to 0.2% of revenue for ROL, versus a peer median of 0.2%.
ROL Competitors Peer median
Other Investing Activities for ROL and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ECLEcolab Inc.LTM Jun 2026$73.1M -522.5%—0.4%
FMCFMC CorporationLTM Mar 2026$17.8M +361.8%-46.7%0.5%
ROLRollins, Inc.LTM Sep 2026$8.03M -29.0%-11.4%0.2%
CTASCintas CorporationLTM Aug 2026$867K -97.1%-88.4%0.0%
RTORentokil Initial plcFY2025$0 +100.0%—0.0%
Peer median (excluding ROL) $433.5K+1.4%-67.6%0.2%

Competitors are the stored peer set for ROL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income350.69M368.6M434.96M466.38M526.71M
Depreciation & Amortization86.56M91.33M99.75M113.22M124.74M
Deferred Income Tax1.65M1.6M(7.64M)(10.34M)19.15M
Stock-Based Compensation14.87M21.22M24.61M29.98M39.71M
Change in Working Capital(39.21M)(28.08M)(28.08M)(24.13M)(65M)
Accounts Receivables(22.44M)(57.89M)(61.67M)(66.65M)(57.87M)
Inventory2.64M(540K)(4.28M)(5.87M)(1.72M)
Accounts Payables(24.21M)304K43.41M47.67M(9.49M)
Other Working Capital4.8M30.05M(5.54M)726K4.07M
Other Non-Cash Items(12.75M)11.27M4.78M32.53M32.8M
Operating Cash Flow401.81M465.93M528.37M607.65M678.11M
Capital Expenditures(27.19M)(30.63M)(32.47M)(27.57M)(28.09M)
Acquisitions (Net)(146.1M)(119.19M)(350.95M)(153.4M)(309.52M)
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities74.33M15.68M10.52M4.74M10.91M
Investing Cash Flow(98.97M)(134.14M)(372.9M)(176.23M)(326.7M)
Debt Repayment(48M)(100M)438M(96M)209.65M
Common Stock Issued00000
Common Stock Repurchased(10.69M)(7.07M)(315.01M)(11.61M)(216.86M)
Dividends Paid(208.66M)(211.62M)(264.35M)(297.99M)(327.9M)
Other Financing Activities(22.81M)(17.33M)(8.06M)(35.11M)(8.47M)
Financing Cash Flow(290.16M)(336.02M)(149.42M)(440.71M)(343.58M)
Effect of Forex Changes(5.86M)(5.73M)2.43M(4.91M)2.55M
Net Change in Cash6.82M(9.96M)8.48M(14.2M)10.37M
Free Cash Flow374.61M435.3M495.9M580.08M650.02M

Rollins, Inc.

NYSE:ROL

Intrinsic Alpha fair value

Locked

Current Price

$37.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.